Dow Today: Johnson & Johnson (JNJ) Leads The Day Higher, Goldman Sachs Group (GS) Lags

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

The Dow Jones Industrial Average ( ^DJI) is trading up 31 points (+0.2%) at 16,591 as of Wednesday, Aug 13, 2014, 9:36 a.m. ET. During this time, 11 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 303.3 million. The NYSE advances/declines ratio sits at 2,023 issues advancing vs. 643 declining with 238 unchanged.
  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

The Dow component leading the way higher looks to be Johnson & Johnson (NYSE: JNJ), which is sporting a 93-cent gain (+0.9%) bringing the stock to $101.56. This single gain is lifting the Dow Jones Industrial Average by 7.04 points or roughly accounting for 22.7% of the Dow's overall gain. Volume for Johnson & Johnson currently sits at 212,184 shares traded vs. an average daily trading volume of 6.2 million shares.

Johnson & Johnson has a market cap of $285.3 billion and is part of the health care sector and drugs industry. Shares are up 9.9% year-to-date as of Tuesday's close. The stock's dividend yield sits at 2.8%.

Johnson & Johnson, together with its subsidiaries, is engaged in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics.

TheStreet Ratings rates Johnson & Johnson as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, reasonable valuation levels and growth in earnings per share. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook.

Holding back the Dow today is Goldman Sachs Group (NYSE: GS), which is lagging the broader Dow index with an 83-cent decline (-0.5%) bringing the stock to $171.50. Volume for Goldman Sachs Group currently sits at 207,611 shares traded vs. an average daily trading volume of 2.4 million shares.

Goldman Sachs Group has a market cap of $75.98 billion and is part of the financial sector and financial services industry. Shares are down 2.8% year-to-date as of Tuesday's close. The stock's dividend yield sits at 1.3%.

The Goldman Sachs Group, Inc. provides investment banking, securities, and investment management services to corporations, financial institutions, governments, and high-net-worth individuals worldwide.

TheStreet Ratings rates Goldman Sachs Group as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, attractive valuation levels, growth in earnings per share, increase in net income and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity.

null

If you liked this article you might like

Buy Stocks That Are Right for You: Cramer's 'Mad Money' Recap (Friday 2/16/18)

Buy Stocks That Are Right for You: Cramer's 'Mad Money' Recap (Friday 2/16/18)

Jim Cramer: These 4 Stocks Seem Attractive Right Here

Jim Cramer: These 4 Stocks Seem Attractive Right Here

Jim Cramer: Drug Stocks on the Move

Jim Cramer: Drug Stocks on the Move

The Decline In Johnson & Johnson Could Be Close to Being Over

The Decline In Johnson & Johnson Could Be Close to Being Over

Opioid Litigants Get Boost From Senate Report

Opioid Litigants Get Boost From Senate Report